A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings

一项采用混合方法的探索性评估,旨在了解监狱环境中医疗服务提供者对阿片类药物使用障碍 (OUD) 的污名化以及对阿片类药物使用障碍药物治疗 (MOUD) 的支持情况。

阅读:1

Abstract

BACKGROUND: In 2019, the state of Maryland passed legislation requiring local detention centers to offer medications for opioid use disorder (MOUD) to all incarcerated individuals who met criteria for opioid use disorder (OUD). Four years later, many facilities remain out of compliance. Beyond issues of staffing, funding, and technical support, stigma may represent a barrier to MOUD implementation. METHODS: Using surveys and interviews among correctional professionals working in Maryland, the current exploratory study sought to identify barriers to MOUD implementation, including measures of provider-based stigma of OUD and support for MOUD. RESULTS: Quantitative and qualitative results revealed moderately high levels of OUD-related stigma and negative attitudes toward MOUD, with multivariable modeling revealing a statistically significant relationship between provider-based stigma of OUD and support for MOUD in correctional settings. CONCLUSION: These findings suggest that stigma may be a significant barrier to MOUD implementation in local detention centers, even in the presence of legal mandates. Further, these results reveal the need for educational and anti-stigma campaigns targeted at correctional professionals who are charged with implementing policies that may contradict their previous learning or correctional training.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。